Insulin (IV) bulk supplier for pharma manufacturers

Insulin (Iv) Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) solution

Available Strengths: 100 units/mL (U-100) in 10 mL vials

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

IV Insulin (Regular) is essential for critical care glucose control, available as 100 units/mL in 10 mL vials. Trusted brands like Humulin® R and Actrapid® offer fast-acting relief. Pharma B2B platforms supply GMP-grade insulin in bulk, ensuring hospital-ready quality, compliance, and reliable global distribution.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: IV Insulin, primarily Regular (short-acting) insulin, is vital in managing diabetic ketoacidosis, hyperkalemia, and perioperative glycemic control. Administered intravenously in hospital settings, it is available as a 100 units/mL solution in 10 mL vials. Key brands include Humulin® R, Novolin® R in the US, and Actrapid®, Insuman® Rapid in the EU. This formulation allows rapid onset and precise control of blood glucose. Pharma B2B platforms facilitate bulk procurement of IV Insulin from GMP-certified manufacturers, ensuring hospital-grade quality, consistent supply, and global regulatory compliance for ICUs, emergency departments, and critical care environments.

Insulin (Iv) — third party manufacturing & bulk supply

Insulin (Iv) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Insulin (Iv) is supplied as Intravenous (IV) solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Insulin (Iv) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Insulin (Iv) →

Back to Listing

Frequently Asked Questions

Insulin (IV) is listed as Intravenous (IV) solution in 100 units/mL (U-100) in 10 mL vials. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Insulin (IV) is referenced against Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.